Sarah Hogan > WilmerHale > Boston, United States > Lawyer Profile

WilmerHale
60 STATE STREET
BOSTON, MA 02109
MASSACHUSETTS
United States

Work Department

Big Data; Cross-Border Transactions; Healthcare; Life Sciences; Technology; Technology Transactions and Licensing

Position

Partner

Career

Sarah Hogan advises companies in the life sciences and digital health industries in connection with structuring and negotiating intellectual property licenses, strategic collaborations and other complex commercial transactions. Drawing on her scientific background and over 15 years in private practice, she delivers practical solutions that lay the groundwork for successful, productive collaborations.

Ms. Hogan has counseled a range of clients in the life sciences, healthcare and technology industries, including startups, venture capital and private equity–backed entities, privately held businesses, hospitals, nonprofit research organizations, and large public companies. She has experience advising on complex matters that include license and collaboration transactions to develop and commercialize pharmaceutical products; cross-industry collaborations, joint development arrangements and joint ventures to develop and deliver products at the intersection of health, technology and life sciences; licensing patents, software and other technology from universities; licensing of data products and data analytics solutions involving health information; licensing of health IT products for both on-premise and hosted (including cloud-based) solutions; and manufacturing, supply and distribution agreements relating to pharmaceutical products at all stages of the product lifecycle.

Memberships

Bar Admissions:
Massachusetts

Education

JD, Northeastern University School of Law, 2005

MS, Genetics, University of New Hampshire, 1999

BS, Biotechnology, Worcester Polytechnic Institute, 1996

Lawyer Rankings

United States > Healthcare > Life sciences

WilmerHale’s primarily Boston-based team advises a range of clients, including diagnostic and medical device corporates, universities and research institutions, and investment banks. Practice co-chair Stuart Falber advises a range of public life science companies on capital markets related matters, while fellow co-chair Lisa Pirozzolo acts in Hatch-Waxman cases and licensing disputes, often appearing before the ITC and the PTAB. Based in New York, David Bassett has an IP litigation focused practice, and often contends with biotech and pharmaceutical patent disputes alongside Robert Gunther, who also handles trade secret cases before arbitration tribunals. Sarah Hogan focuses on the life sciences and digital health industries, and has a great deal of experience in the negotiation of IP licenses and strategic collaborations.